SynKinase

Tivozanib

CHF 0.00
In stock
SYN-1013-M0011 mgCHF 114.00
SYN-1013-M0055 mgCHF 184.00
SYN-1013-M01010 mgCHF 263.00
SYN-1013-M05050 mgCHF 858.00
SYN-1013-M100100 mgINQ
 
More Information
Product Details
Synonyms AV-951
Product Type Chemical
Properties
Formula C22H19ClN4O5
MW 454.9
CAS 475108-18-0
Purity Chemicals ≥95%
Appearance Solid.
Solubility Soluble in DMSO. Slightly soluble (<1mg/ml) in ethanol.
Declaration Manufactured by SynKinase.
Other Product Data Target: VEGFR | Kinase Group: RTK | Substrate: Tyrosine

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
InChi Key SPMVMDHWKHCIDT-UHFFFAOYSA-N
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description
Tivozanib is a potent inhibitor of VEGFR-1, 2 & 3 (IC(50) 0.21, 0.16 and 0.24nM respectively).
Product References
  1. Biologic and clinical activity of tivozanib (AV-951, KRN-951), a selective inhibitor of VEGF receptor-1, -2, and -3 tyrosine kinases, in a 4-week-on, 2-week-off schedule in patients with advanced solid tumors: F.A. Eskens, et al.; Clin. Cancer Res. 17, 7156 (2011)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.